You have 9 free searches left this month | to do more

incmga00012

Incmga00012 is a drug used to treat Advanced Solid Tumors, Bladder Cancer, Breast Cancer, and other conditions. Incmga00012 is being actively studied in 8 studies and prior, has been studied in 1.

Top SponsorsTop SitesTop Investigators
Incyte CorporationMd Anderson Cancer CenterSook Ryun Park
Asan Medical CenterCedars-Sinai Medical Center
BriaCell Therapeutics CorporationDana Farber Cancer Institute
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Glioblastoma
  • INCMGA00012
  • +3 more
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
2022-02-11
Feb 11, 2022
B
Recruiting
  • Breast Cancer Female
  • Breast Neoplasm Female
  • SV-BR-1-GM
  • +4 more
  • Santa Rosa, California
  • +5 more
2022-03-10
Mar 10, 2022
A
Not yet recruiting
  • Esophageal Cancer
  • INCMGA00012
  • (no location specified)
2020-07-27
Jul 27, 2020
M
Recruiting
  • Well-differentiated/Dedifferentiated Liposarcoma
  • Basking Ridge, New Jersey
  • +6 more
2021-12-21
Dec 21, 2021
I
Not yet recruiting
  • Retroperitoneal Sarcoma
  • Resectable Sarcoma
  • Bordeaux, France
  • +3 more
2022-03-04
Mar 4, 2022
P
Recruiting
  • Cancer of the Head and Neck
  • Portland, Oregon
    Portland Providence Medical Center
2021-09-01
Sep 1, 2021
I
Recruiting
  • Advanced Solid Tumors
  • New Haven, Connecticut
  • +20 more
2022-04-06
Apr 6, 2022
I
Recruiting
  • Ovarian Cancer
  • +10 more
  • West Hollywood, California
  • +26 more
2022-04-06
Apr 6, 2022
I
Completed
  • Lung Cancer
  • +10 more
  • Birmingham, Alabama
  • +19 more
2022-01-04
Jan 4, 2022